This page is part of the FHIR Specification v6.0.0-ballot1: Release 6 Ballot (1st Draft) (see Ballot Notes). The current version is 5.0.0. For a full list of available versions, see the Directory of published versions
Example of conditiondefinition
{
"resourceType" : "ConditionDefinition",
"id" : "example",
"text" : {
"status" : "extensions",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative: ConditionDefinition</b><a name=\"example\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource ConditionDefinition "example" </p></div><p><b>StructureDefinition Work Group</b>: pc</p><p><b>url</b>: <code>http://hl7.org/fhir/ConditionDefinition/example</code></p><p><b>identifier</b>: id:\u00a0<a href=\"http://terminology.hl7.org/5.4.0/NamingSystem-uri.html\">#</a>urn:oid:2.16.840.1.113883.4.642.25.1</p><p><b>name</b>: Hyperlipidemia</p><p><b>title</b>: Hyperlipidemia Status</p><p><b>status</b>: draft</p><p><b>date</b>: 2019-05-26T10:44:00+10:00</p><p><b>publisher</b>: HL7 International / Patient Care</p><p><b>contact</b>: </p><p><b>description</b>: Hyperlipidemia Status</p><p><b>code</b>: Hyperlipidemia (disorder) <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://browser.ihtsdotools.org/\">SNOMED CT</a>#55822004)</span></p><p><b>hasSeverity</b>: false</p><p><b>hasBodySite</b>: false</p><p><b>hasStage</b>: false</p><p><b>definition</b>: <a href=\"https://med.stanford.edu/content/dam/sm/cerc/documents/Hyperlipidemia%20Management%20Protocol.pdf\">https://med.stanford.edu/content/dam/sm/cerc/documents/Hyperlipidemia%20Management%20Protocol.pdf</a></p><p><b>observation</b>: <a href=\"http://example.org/fhir/ObservationDefinition/lipid-panel\">http://example.org/fhir/ObservationDefinition/lipid-panel</a>, <a href=\"http://example.org/fhir/ObservationDefinition/cholesterol\">http://example.org/fhir/ObservationDefinition/cholesterol</a>, <a href=\"http://example.org/fhir/ObservationDefinition/triglyceride\">http://example.org/fhir/ObservationDefinition/triglyceride</a>, <a href=\"http://example.org/fhir/ObservationDefinition/cholesterol-hdl\">http://example.org/fhir/ObservationDefinition/cholesterol-hdl</a>, <a href=\"http://example.org/fhir/ObservationDefinition/cholesterol-ldl\">http://example.org/fhir/ObservationDefinition/cholesterol-ldl</a></p><h3>Medications</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Code</b></td></tr><tr><td style=\"display: none\">*</td><td>Gemfibrozil <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://terminology.hl7.org/5.4.0/CodeSystem-v3-rxNorm.html\">RxNorm</a>#203151 "fenoldopam mesylate")</span></td></tr></table><h3>Plans</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Reference</b></td></tr><tr><td style=\"display: none\">*</td><td><a href=\"broken-link.html\">http://acme.com/fhir/PlanDefinition/fd0e32d8-2ebd-4211-9e50-8983efddc2c6</a></td></tr></table></div>"
},
"extension" : [{
"url" : "http://hl7.org/fhir/StructureDefinition/structuredefinition-wg",
"valueCode" : "pc"
}],
"url" : "http://hl7.org/fhir/ConditionDefinition/example",
"identifier" : [{
"system" : "urn:ietf:rfc:3986",
"value" : "urn:oid:2.16.840.1.113883.4.642.25.1"
}],
"name" : "Hyperlipidemia",
"title" : "Hyperlipidemia Status",
"status" : "draft",
"date" : "2019-05-26T10:44:00+10:00",
"publisher" : "HL7 International / Patient Care",
"contact" : [{
"telecom" : [{
"system" : "url"
}]
}],
"description" : "Hyperlipidemia Status",
"code" : {
"coding" : [{
"system" : "http://snomed.info/sct",
"code" : "55822004",
"display" : "Hyperlipidemia (disorder)"
}]
},
"hasSeverity" : false,
"hasBodySite" : false,
"hasStage" : false,
"definition" : ["https://med.stanford.edu/content/dam/sm/cerc/documents/Hyperlipidemia%20Management%20Protocol.pdf"],
"observation" : ["http://example.org/fhir/ObservationDefinition/lipid-panel",
"http://example.org/fhir/ObservationDefinition/cholesterol",
"http://example.org/fhir/ObservationDefinition/triglyceride",
"http://example.org/fhir/ObservationDefinition/cholesterol-hdl",
"http://example.org/fhir/ObservationDefinition/cholesterol-ldl"],
"medication" : [{
"code" : {
"coding" : [{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"code" : "203151",
"display" : "fenoldopam mesylate"
}],
"text" : "Gemfibrozil"
}
}],
"plan" : [{
"reference" : {
"reference" : "http://acme.com/fhir/PlanDefinition/fd0e32d8-2ebd-4211-9e50-8983efddc2c6"
}
}]
}
Usage note: every effort has been made to ensure that the
examples are correct and useful, but they are not a normative part
of the specification.